Therefore, TNF is capable of upregulating ICAM-1, MHC-I and, to a lesser extent, CD83 and PD-L1 on multiple pediatric sarcoma cell lines without promoting tumor growth in vitro, and thus was further assessed for its immunostimulatory activity. This evidence concerns the gene CD83 and sarcoma.